Research Type: Extramural
Professor Clarke’s team has been unravelling the complexities of breast cancer by providing new insight into the structure of the normal breast and how progesterone may be linked with cancer risk.
Associate Professor Phoebe Phillips and her team have come up with a new way to target the cells that help the spread of aggressive pancreatic cancer.
Professor Baker and his team aim to develop a new blood-based test to detect bowel cancer in its early stages.
Dr Wilmott and his team are focused on finding treatments for the more than 40% of patients that are not cured with our best current therapies.
This project will focus on developing adaptive radiotherapy for locally advanced lung, prostate and oligometastatic cancer.
This project will lay the foundations for possible clinical trials of drugs targeting the ELF5 protein as a way of preventing hormone therapy resistance in breast cancer.
Dr Wong’s research is focused on the chemical changes in DNA and RNA that are associated with acute myeloid leukaemia.
This project aims to develop a way to increase the effectiveness of chemotherapy in pancreatic cancer using a dual treatment approach that targets the production of protective tissue in the tumour.
Dr Debbie Watson will develop a potential new treatment strategy using manipulated stem cell transplantation combined with drugs that block development of graft-versus-host disease.
Professor Maija Kohonen-Corish and her team have been developing crucial evidence on MCC protein alteration with the aim of creating new treatment targets and biomarkers for bowel cancer.